New selective bradykinin receptor antagonists and bradykinin B2 receptor characterization.
Substantial progress has been made recently in the field of kinin pharmacology with the identification of sensitive bioassay organs and the discovery of bradykinin B2 receptor antagonists. Data obtained with such compounds in various laboratories support the hypothesis that kinins act on multiple (at least two) receptor types. Domenico Regoli and colleagues review here the basic criteria of receptor characterization as they apply to kinins and present a critical analysis of the bioassay organs and B2 receptor antagonists currently used in kinin pharmacology.
Regoli
D
D
Department of Pharmacology, Medical School, University of Sherbrooke, Quebec, Canada.
Rhaleb
N E
NE
Dion
S
S
Drapeau
G
G
D000818:Animals; D001920:Bradykinin / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D018002:Receptors, Bradykinin; D017981:Receptors, Neurotransmitter / Q000378:metabolism*; D013329:Structure-Activity Relationship
D018002:Receptors, Bradykinin; D017981:Receptors, Neurotransmitter; D001920:Bradykinin